Linsidomine
CARDIOVASCULAR SYSTEM
Also known as: linsidomine HCl, linsidomine hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Linsidomine is a drug catalogued in DrugCentral.
- ATC code: C01DX18 (Other vasodilators used in cardiac diseases).
- Molecular formula: C6H10N4O2; molecular weight 170.17 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01DX18 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › VASODILATORS USED IN CARDIAC DISEASES › Other vasodilators used in cardiac diseases |
Chemical structure
| Molecular formula | C6H10N4O2 |
|---|---|
| Molecular weight | 170.17 g/mol |
| CAS number | — |
| InChIKey | FKDHHVKWGRFRTG-UHFFFAOYSA-N |
| PubChem CID | 5219 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Linsidomine?
Linsidomine has the molecular formula C6H10N4O2 and a molecular weight of 170.17 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4589 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1189150 — compound record and bioactivity
- PubChem CID 5219 — chemical identifiers
- DrugBank DB13400 — drug record
- FDA UNII 5O5U71P6VQ — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.